Navigation Links
Disease and Therapy Review: Bladder Cancer Now Available at ReportsandReports
Date:6/29/2010

DALLAS, June 29, 2010 /PRNewswire/ -- ReportsandReports announces it will carry the Disease and Therapy Review: Bladder Cancer Market Research Report in its Store

Browse the complete Report on: http://www.reportsandreports.com/market-reports/disease-and-therapy-review-bl adder-cancer/

The Bladder Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the cancer market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

    Table of Contents

    I.OVERVIEW

    General description of the condition

    II.INCIDENCE AND PREVALENCE

    - Incidence Table (Canada, US, Mexico, France, Germany, Greece,
      Italy, Russian Federation, Spain, Sweden, UK, China, India, Japan,
      Europe, Worldwide)
    - Prevalence Table (Canada, US, Mexico, France, Germany, Italy,
      Spain, UK, China, India, Japan, Worldwide)
    - Mortality Table (Canada, US, Mexico, France, Germany, Greece,
      Italy, Russian Federation, Spain, Sweden, UK, China, India, Japan,
      Europe, Worldwide)

    III.DIAGNOSIS

    - Symptoms and signs
    - Laboratory findings
    - Imaging
    - Cystouresthroscopy and biopsy
    - Cellular classification

    IV. TREATMENT

    - Surgical therapy
    - Radiotherapy
    - Chemotherapy
    - Interstitial implantation of radioisotopes
    - Clinical trials
    - Outcomes by stage


    V.DOSING AND TREATMENT COSTS
    VI.MARKET SIZE
    VII.COMMENTS
    VIII.REFERENCES/RESOURCES
    Browse all HealthCare Reports at
http://www.reportsandreports.com/market-research/healthcare/
    Browse all Timely Data resources Reports at
http://www.reportsandreports.com/Publishers/timely-data-resources/

Related Reports

Disease and Therapy Review: Colorectal Cancer ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-co lorectal-cancer/)

Disease and Therapy Review: Cervical Cancer ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-ce rvical-cancer/)

Disease and Therapy Review: Prostate Cancer ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-pr ostate-cancer/)

Cancer Bladder Cancer Therapy Area Pipeline Report ( http://www.reportsandreports.com/market-reports/cancer-bladder-cancer-therapy -area-pipeline-report/)

Disease and Therapy Review: Chronic Obstructive Pulmonary Disease (COPD) (http://www.reportsandreports.com/market-reports/disease-and-therapy-review-c hronic-obstructive-pulmonary-disease/)

Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD) (http://www.reportsandreports.com/market-reports/disease-and-therapy-review-g astroesophageal-reflux-disease-ger/)

Disease and Therapy Review: Asthma( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-as thma/)

Disease and Therapy Review: Impetigo( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-im petigo/)

Disease and Therapy Review: Onychomycosis ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-on ychomycosis/)

Disease and Therapy Review: Ulcerative Colitis ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-ul cerative-colitis/)

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

    Contact:

    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    http://www.reportsandreports.com/
    http://reportsnreports.wordpress.com/
    http://reportsandreports.blogspot.com/



'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
2. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
3. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
6. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
7. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
8. Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
9. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
10. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
11. AAAAI: Call for Entries: Have You Written a Story on Allergic Disease? Win $1000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... WEST PALM BEACH, Fla. , Feb. 16, ... molecular diagnostics company revolutionizing the development of liquid ... that it has entered into an exclusive license ... who will distribute MDNA,s proprietary liquid biopsy test ... in South Korea . This ...
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
Breaking Biology Technology:
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
Breaking Biology News(10 mins):